PAX5 and melanoma: Our results show that PAX5 gene is an efficient marker to measure the effects of methylation inhibitors such as 5-azacytidine and 5-azadeoxycytidine at in vitro systems for malignant melanoma because the methylation levels are all the same in primary tissue and culture systems.